1887

Abstract

A novel hepatitis B virus (HBV) variant was detected in the sera of two children in The Gambia, West Africa. The children had been immunized with plasma-derived vaccine and had developed antibody titres of 1448 international units × 10 (mIU)/ml and 133 mIU/ml respectively against the hepatitis B surface antigen (HBsAg). Despite the protective levels of antibodies, HBV DNA was subsequently detected in both children. The complete surface (S) protein gene sequence demonstrated that this HBV isolate was closely related to the subtype. However, five nucleotide changes were identified and two of these were unique to the Gambian isolate. One of these changes was within the region of the S gene coding for the immunodominant determinant of the S protein. A unique nucleotide change from adenosine to guanosine at nucleotide 421 was found, resulting in an amino acid substitution at residue 141 from lysine to glutamic acid. Previous studies have shown that amino acids 141 to 146 are critical for binding to the protective anti-HBsAg antibodies. The presence of a variant HBV in these children suggests the emergence of a novel strain of HBV which can evade immune recognition. This has potential implications for HBV diagnosis and prophylaxis.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-75-2-443
1994-02-01
2022-05-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/75/2/JV0750020443.html?itemId=/content/journal/jgv/10.1099/0022-1317-75-2-443&mimeType=html&fmt=ahah

References

  1. Brown S. E., Howard C. R., Zuckerman A. J., Steward M. W. 1984a; Determination of the affinity of antibodies to hepatitis B surface antigen in human sera. Journal of Immunological Methods 72:41–48
    [Google Scholar]
  2. Brown S. E., Howard C. R., Zuckerman A. J., Steward M. W. 1984b; Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides. Lancet ii:184–187
    [Google Scholar]
  3. Carman W. F., Zanneti A. R., Karayiannis P., Waters J., Manzillo G., Tanzi E., Zuckerman A. J., Thomas H. C. 1990; Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325–329
    [Google Scholar]
  4. Chotard J., Inskip H. M., Hall A. J., Loik F., Mendy M., Whittle H., George M. O., Lowe Y. 1992; The Gambia hepatitis intervention study: follow-up of a cohort of children vaccinated against hepatitis B. Journal of Infectious Diseases 166:764–768
    [Google Scholar]
  5. Fortuin M., Chotard J., Jack A. D., Maine N. P., Mendy M., Hall A. J., Inskip H. M., George M. O., Whittle H. C. 1993; Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation. Lancet 341:1129–1131
    [Google Scholar]
  6. Girones R., Miller R. H. 1989; Mutation rate of hepadnavirus genome. Virology 170:595–597
    [Google Scholar]
  7. Hadler S. C., Francis D. P., Maynard J. E., Thompson S. E., Judson F. N., Echenberg D. F., Ostrow D. G., O’Malley P. M., Penley K. A., Altman N. L., Braff E., Shipman G. F., Coleman P. J., Mandel E. J. 1986; Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. New England Journal of Medicine 315:209–214
    [Google Scholar]
  8. Harrison T. J., Hopes E. A., Oon C. J., Zanetti A. R., Zuckerman A. J. 1991; Independent emergence of a vaccine-induced escape mutant of hepatitis B virus. Journal of Hepatology 13: suppl. 4 105–107
    [Google Scholar]
  9. Howard C. R., Allan J., Chen S. -H., Brown S. E., Steward M. W. 1986; Progress towardsa synthetic hepatitis B vaccine. Protides of the Biological Fluids 34:133–136
    [Google Scholar]
  10. McMahon G., Ehlich P. H., Moustafa Z. A., McCarthy L. A., Dottovio D., Tolpin M. D., Nadler P. I., Ostberg L. 1992; Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology 15:757–766
    [Google Scholar]
  11. Neurath A. R., Pride M. W., Strick N., Thanavala Y. M. 1990; Toleration of amino acid substitutions within hepatitis B virus envelope protein epitopes established by peptide replacement set analysis. I. Region S (139-147). Peptide Research 3:116–122
    [Google Scholar]
  12. Norder H., Hammas B., Löfdahl S., Couroucé A. -M., Magnius L. O. 1992a; Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. Journal of General Virology 73:1201–1208
    [Google Scholar]
  13. Norder H., Couroucé A. -M., Magnius L. O. 1992b; Molecular basis of hepatitis B virus serotype variations within the four major serotypes. Journal of General Virology 73:3141–3145
    [Google Scholar]
  14. Okamoto H., Imai M., Tsuda F., Tanaka T., Miyakawa Y., Mayumi M. 1987; Point mutations in the S-gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype advr and adwr. Journal of Virology 61:3030–3034
    [Google Scholar]
  15. Radziwell G., Tucker W., Schaller H. 1990; Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. Journal of Virology 64:613–620
    [Google Scholar]
  16. Saiki P. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuichi R., Horn G. T., Mullis K. B., Erlich H. A. 1988; Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491
    [Google Scholar]
  17. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual, 2nd edn. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  18. Sanger F. S., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences, U.S.A 74:5463–5467
    [Google Scholar]
  19. Steward M. W., Sisley B. M., Stanley C., Brown S. E., Howard C. R. 1986; Humoral and cellular responses in man following immunisation with hepatitis B vaccine: analysis with synthetic peptides. Protides of the Biological Fluids 34:137–140
    [Google Scholar]
  20. Steward M. W., Partidos C. D., D’Mello F., Howard C. R. 1993; Specificity of antibodies reactive with hepatitis B surface antigen following immunization with synthetic peptides. Vaccine in press
    [Google Scholar]
  21. Stirk H. J., Thornton J. M., Howard C. R. 1992; A topological model for hepatitis B surface antigen. Intervirology 33:148–158
    [Google Scholar]
  22. Vaudin M., Wolstenholme A. J., Tsiquaye K. N., Zuckerman A. J., Harrison T. J. 1988; The complete nucleotide sequence of the genome of a hepatitis B virus isolated from a naturally infected chimpanzee. Journal of General Virology 69:1383–1389
    [Google Scholar]
  23. Whittle H., Inskip H., Bradley A. K., McLaughlan K., Shenton F., Lamp W., Eccles J., Baker B. A., Hall A. J. 1990; The pattern of childhood hepatitis B infection in two Gambian villages. Journal of Infectious Diseases 161:1112–1115
    [Google Scholar]
  24. Whittle H. C., Inskip H., Hall A. J., Mendy M., Downes R., Hoare S. 1991; Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia. Lancet 337:747–750
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-75-2-443
Loading
/content/journal/jgv/10.1099/0022-1317-75-2-443
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error